SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,253,172 | -23.0% | 10,338 | -27.0% | 0.00% | 0.0% |
| Q2 2023 | $1,626,510 | -11.5% | 14,155 | +6.1% | 0.00% | -50.0% |
| Q1 2023 | $1,838,238 | +3.7% | 13,337 | -36.4% | 0.00% | +100.0% |
| Q4 2022 | $1,772,705 | +13.4% | 20,978 | +48.3% | 0.00% | -50.0% |
| Q3 2022 | $1,563,000 | +39.8% | 14,144 | -42.9% | 0.00% | +100.0% |
| Q2 2022 | $1,118,000 | -5.3% | 24,792 | +0.6% | 0.00% | 0.0% |
| Q1 2022 | $1,180,000 | -20.6% | 24,638 | -28.8% | 0.00% | 0.0% |
| Q4 2021 | $1,487,000 | +3.9% | 34,616 | -45.4% | 0.00% | -50.0% |
| Q3 2021 | $1,431,000 | +85.4% | 63,441 | +138.7% | 0.00% | +100.0% |
| Q2 2021 | $772,000 | -4.8% | 26,573 | -1.4% | 0.00% | 0.0% |
| Q1 2021 | $811,000 | -90.7% | 26,956 | -66.7% | 0.00% | -90.0% |
| Q4 2020 | $8,697,000 | +55.4% | 80,882 | +3.1% | 0.01% | +42.9% |
| Q3 2020 | $5,597,000 | -0.4% | 78,444 | -14.3% | 0.01% | 0.0% |
| Q2 2020 | $5,620,000 | +89.8% | 91,568 | +1.7% | 0.01% | +40.0% |
| Q1 2020 | $2,961,000 | -37.4% | 90,018 | -5.4% | 0.01% | 0.0% |
| Q4 2019 | $4,733,000 | +103.6% | 95,153 | +6.2% | 0.01% | +66.7% |
| Q3 2019 | $2,325,000 | -52.9% | 89,583 | +1.0% | 0.00% | -57.1% |
| Q2 2019 | $4,938,000 | +135.4% | 88,733 | +404.0% | 0.01% | +133.3% |
| Q1 2019 | $2,098,000 | +20.6% | 17,605 | +10.5% | 0.00% | 0.0% |
| Q4 2018 | $1,739,000 | -53.7% | 15,938 | -31.4% | 0.00% | -50.0% |
| Q3 2018 | $3,753,000 | +77.7% | 23,234 | +45.4% | 0.01% | +50.0% |
| Q2 2018 | $2,112,000 | +17.3% | 15,976 | -34.3% | 0.00% | +33.3% |
| Q1 2018 | $1,801,000 | +32.9% | 24,310 | -0.2% | 0.00% | +50.0% |
| Q4 2017 | $1,355,000 | +20.0% | 24,353 | -2.1% | 0.00% | 0.0% |
| Q3 2017 | $1,129,000 | +218.0% | 24,881 | +136.1% | 0.00% | +100.0% |
| Q2 2017 | $355,000 | +63.6% | 10,540 | +44.0% | 0.00% | 0.0% |
| Q1 2017 | $217,000 | -22.2% | 7,318 | -28.1% | 0.00% | 0.0% |
| Q4 2016 | $279,000 | -78.8% | 10,179 | -52.5% | 0.00% | -75.0% |
| Q3 2016 | $1,316,000 | +355.4% | 21,423 | +41.4% | 0.00% | +300.0% |
| Q2 2016 | $289,000 | +15.1% | 15,151 | +17.9% | 0.00% | 0.0% |
| Q1 2016 | $251,000 | -46.1% | 12,851 | +6.3% | 0.00% | -50.0% |
| Q4 2015 | $466,000 | +25.9% | 12,086 | +4.8% | 0.00% | 0.0% |
| Q3 2015 | $370,000 | +15.6% | 11,536 | +9.5% | 0.00% | +100.0% |
| Q2 2015 | $320,000 | +32.2% | 10,532 | -36.9% | 0.00% | 0.0% |
| Q4 2014 | $242,000 | -14.5% | 16,697 | +24.4% | 0.00% | -50.0% |
| Q3 2014 | $283,000 | -29.2% | 13,422 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $400,000 | +66.0% | 13,422 | +33.8% | 0.00% | 0.0% |
| Q1 2014 | $241,000 | -84.9% | 10,028 | -70.4% | 0.00% | -85.7% |
| Q3 2013 | $1,597,000 | -30.0% | 33,822 | -43.6% | 0.01% | -36.4% |
| Q2 2013 | $2,281,000 | – | 59,961 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |